Comparison of Use of Propiverine at 45 mg and Combined Treatment of Propiverine 30 mg and Mirabegron in Patients with Overactive Bladder Who did not Benefit from Propiverine 30 mg Treatment
Objective: There are many anti-cholinergic drugs that are used to treat overactive bladder. Mirabegron was created to lessen the many side effects of these drugs, especially acute urinary retention. The use of mirabegron along with anti-cholinergic is a safe and effective treatment method. In additi...
Saved in:
Main Authors: | İrfan Şafak Barlas, Selamettin Demir |
---|---|
Format: | Article |
Language: | English |
Published: |
Galenos Publishing House
2024-04-01
|
Series: | Gazi Medical Journal |
Subjects: | |
Online Access: | https://gazimedj.com/articles/comparison-of-use-of-propiverine-at-45-mg-and-combined-treatment-of-propiverine-30-mg-and-mirabegron-in-patients-with-overactive-bladder-who-did-not-benefit-from-propiverine-30-mg-treatment/doi/gmj.2023.3677 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
An open-label, randomized, post-authorization study of mirabegron in Chinese participants with overactive bladder
by: Zhipeng Zhang, et al.
Published: (2025-01-01) -
Comparison Of Outcome And Side Effects Profile Of Treatment Of Overactive Bladder With Different Classes Of Drugs
by: Nazish Sarfraz, et al.
Published: (2023-12-01) -
The Management of Children and Adolescents with Overactive Bladder Refractory to Treatment with Parasacral Transcutaneous Electrical Nerve Stimulation
by: Carlos Eduardo Rocha Macedo, et al.
Published: (2025-01-01) -
Mechanism of action of Xipayimaizibizi oral liquid on outlet obstruction-induced overactive bladder: An integrated study
by: Menglu Wang, et al.
Published: (2025-01-01) -
Efficacy and safety of solifenacin for overactive bladder: An updated systematic review and meta-analysis
by: I Gede Yogi Prema Ananda, et al.
Published: (2025-01-01)